In the STEP-1 trial of 1,961 adults (Wilding and colleagues, Once-Weekly Semaglutide in Adults with Overweight or Obesity, New England Journal of Medicine, 2021), participants on semaglutide 2.4 mg lost an average of 14.9 percent of their body weight at 68 weeks, compared to 2.4 percent on placebo
Injections deliver the peptide to systemic circulation more reliably
Product Details and Features: Active Ingredient: Cyanocobalamin (Vitamin B12)
It is not used to mix injections
Common side effects include: Injection site reactions , such as redness, swelling, or pain
See what a recent study found in the What It Does section of the Turmeric and Curcumin Supplements and Spices Review